Center For Weight Loss Surgery
12815 120th Avenue Northeast · Kirkland, WA 98034
5.0(15 Google reviews · 2 in past year)
TelehealthAccepts insurance
Listing updated Oct 2, 2026
Templum Aesthetics & Wellness
Templum Aesthetics & Wellness · 808 6th Street South · Kirkland, WA 98033
5.0· 123 Google reviews
Listing updated October 2, 2026
Retatrutide outlook for this practice
No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.
Care described on the practice's website
- Medically supervised weight loss
About this practice
Templum Aesthetics & Wellness is a medical aesthetics practice in Kirkland, Washington. Its website describes Botox, Dysport, Daxxify and Xeomin injections, laser and skin treatments including SmartXide Pro and CryoTouch MD, and IV therapy, and the listing also shows weight-loss care. On Google it holds a 5.0-star rating across 123 reviews dating back to 2024, 79 of them in the past year. Reviewers most often mention the providers' knowledge and the staff, and 16 reviews mention results.
Services & access
| Advertises semaglutide today | Not listed |
| Advertises tirzepatide today | Not listed |
| Telehealth visits | Not listed |
| Cash pay accepted | — |
| Accepts insurance — per practice website | Yes |
| Accepting new patients — per practice website | Yes |
"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.
Review activity
★ 5.0
Google rating · 123 reviews
79
reviews in the past year (avg ★ 5.0)
Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-27. Read the reviews themselves on the practice's Google listing.
What patients say
Rated ★5.0 across 123 Google reviews. Of the 100 reviews we analyzed, 100 (100%) are positive (4–5★) and 0 (0%) are negative (1–2★).
What patients like
- Knowledgeable, professional providers33 reviews
- Friendly, helpful staff19 reviews
- Weight-loss results16 reviews
- Feeling listened to9 reviews
Common complaints
No negative reviews among those we analyzed.
5★
100
4★
0
3★
0
2★
0
1★
0
Most recent Google reviews
Jessica B.★★★★★2026-09-27I absolutely love my lips! 🥰 Jessica did such an amazing job, and I’m so happy with how they turned out. They look natural and not overdone, which is exactly what I wanted. I’ve known Jessica for years, so I already knew I was in good hands. She’s incredibly talented, makes you feel comfortable, and really listens to what you want. I’m so happy with my results and would definitely recommend her!
Gwen K.★★★★★2026-09-25Pegi is the best! Aside from being so warm, funny and great to talk to, I trust her implicitly! Her skill and expertise is top notch!
Dana C.★★★★★2026-09-15Pegi is the absolute BEST! I highly recommend her and her team!
Ellen M.★★★★★2026-09-14Always the best results! Thank you Peggy and all. Love love this beautiful place! I travels miles and miles for my service.
Laura R.★★★★★2026-08-10Pegi is extremely knowledgable about the products she uses. She puts me at ease and I have been extremely satisfied with the results.
Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.
Nearby providers in Kirkland
A Greater Whole - Dr. Tacita Robertson
11702 98th Avenue Northeast · Kirkland, WA 98034
5.0(32 Google reviews · 4 in past year)
Accepts insurance
Listing updated Oct 2, 2026
Accepts insurance
Listing updated Oct 2, 2026
Accepts insurance
Listing updated Oct 2, 2026
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026
Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.
- Development
- Phase 3 complete
- FDA status
- Submission planned — Q1 2027 (Lilly guidance)
- Availability
- Not commercially available
- Access routes
- Clinical trials, or Lilly's expanded access program (physician must apply)
Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)
Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs